Cargando…
Use of Whole Genome Sequencing for Diagnosis and Discovery in the Cancer Genetics Clinic
Despite the potential of whole-genome sequencing (WGS) to improve patient diagnosis and care, the empirical value of WGS in the cancer genetics clinic is unknown. We performed WGS on members of two cohorts of cancer genetics patients: those with BRCA1/2 mutations (n = 176) and those without (n = 82)...
Autores principales: | Foley, Samantha B., Rios, Jonathan J., Mgbemena, Victoria E., Robinson, Linda S., Hampel, Heather L., Toland, Amanda E., Durham, Leslie, Ross, Theodora S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444225/ https://www.ncbi.nlm.nih.gov/pubmed/26023681 http://dx.doi.org/10.1016/j.ebiom.2014.12.003 |
Ejemplares similares
-
Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
por: Ross, Theodora S, et al.
Publicado: (2014) -
Towards a Therapeutic Reduction of Imatinib Refractory Myeloproliferative Neoplasm-Initiating Cells
por: Philips, Steven T., et al.
Publicado: (2013) -
Functional Interaction of BRCA1 and CREBBP in Murine Hematopoiesis
por: Holmstrom, Sam R., et al.
Publicado: (2019) -
Mutation discovery in mice by whole exome sequencing
por: Fairfield, Heather, et al.
Publicado: (2011) -
BRCA1 and TP53 codeficiency causes a PARP inhibitor–sensitive erythroproliferative neoplasm
por: Lopez-Perez, Gerardo, et al.
Publicado: (2022)